L. Mont Girbau-rekin lankidetzan egindako argitalpenak (6)

2022

  1. Personalized assessment of the cumulative complication risk of the atrial fibrillation ablation track: The AF-TRACK calculator

    Heart Rhythm O2, Vol. 3, Núm. 6, pp. 656-664

2014

  1. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: A multicentre, randomized, controlled trial (SARA study)

    European Heart Journal, Vol. 35, Núm. 8, pp. 501-507

2013

  1. Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure

    European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884

2012

  1. New evidence, new controversies: A critical review of the European society of cardiology 2010 clinical practice guidelines on atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 65, Núm. 1, pp. 7-13

2010

  1. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients

    Europace, Vol. 12, Núm. 8, pp. 1084-1089

  2. Skeletal myoblast implants induce minor propagation delays, but do not promote arrhythmias in the normal swine heart

    Europace, Vol. 12, Núm. 11, pp. 1637-1644